<DOC>
	<DOCNO>NCT00407173</DOCNO>
	<brief_summary>This study open-label , single-dose , parallel group study evaluate effect age gender pharmacokinetics , safety , tolerability HCV-796 administer orally healthy subject .</brief_summary>
	<brief_title>Study Evaluate Effects Age &amp; Gender PK , Safety &amp; Tolerability HCV-796 Administered Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion : Men nonlactating nonpregnant woman , age 18 45 , &gt; 65 year . Men must agree practice barrier contraception 12 week last test article administration . Estimated ( calculate ) creatinine clearance must within ageappropriate normal range . Exclusion : History seizure . History rhabdomyolysis . History thyroid disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>